Article Details
Retrieved on: 2018-03-21 18:00:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Another company in Rothberg's accelerator, LAM Therapeutics, has raised nearly $100 million for its operations to improve drug development for patients with cancer and rare diseases using <b>artificial intelligence</b>. The Rothberg Catalyzer Prize will help fund students' ideas at Yale, Brown, Carnegie ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here